[1] Zhang J,Jia Q,Zou S,et al.Thymidine kinase 1:a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinomas patients[J].Oncol Rep,2006,15(2):455-461.
[2] 张伟,龚磊,杨锦雷,等.血清胸苷激酶1在食管鳞癌诊治中的应用价值[J].安徽医学,2018,39(9):1125-1127.
[3] 李娟,向保云,聂艳霞,等.血液恶性肿瘤患者血清脂蛋白a和胸苷激酶1的表达及临床意义[J].新乡医学院学报,2018,35(8):694-696,700.
[4] 赵可,宋腾,陈海珠,等.非霍奇金淋巴瘤患者血清胸苷激酶1表达临床意义探讨[J].中华肿瘤防治杂志,2018, 25(9):668-672.
[5] 葛均波,徐永健,梅长林,等.内科学[M].8版.北京:人民卫生出版社,2013:578.
[6] 涂植光.依托现代科学管理和技术,开展肿瘤标志物研究和应用[J].中华检验医学杂志,2006,29(4):289-292.
[7] He Q,Fornander T,Skog S,et a1.Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following operation of early breast cancer patients[J].Anticancer Res,2006,26(6C):4753-4760.
[8] Weagel E G,Meng W,Townsend M H,et al.Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia[J].Onco Targets Ther,2017,10:4355-4367.
[9] 徐文静,刘德干.血清胸苷激酶1与肿瘤[J].国际肿瘤学杂志,2013,40(9):643-645.
[10] Votava T,Topolcan O,Cerna Z,et al.Changes of serum thymidine kinase in children with acute leukemia[J].Anticaneer Res,2007,27(4A):1925-1928.
[11] 徐文鑫,梅序桥,刘慧丽.血清胸苷激酶1在儿童急性淋巴细胞白血病诊疗中的应用[J].检验医学与临床,2015,12(16):2311-2313.
[12] Hagag A A,Saad M A, Mohamed S A.Clinical significance of thymidine kinase in Egyptian children with acute lymphoblastic leukemia[J].South Asian J Cancer,2015,4(2):72-74.
[13] López M B, Vilchis O A, Salazar G M,et al.Thymidine Kinase: A Biomarker for Recently Diagnosed Acute Leukemia in Pediatric Patients According to the Cell Line Involved[J].Arch Med Res,2015,46(8):630-634.
[14] Andrea B,Gunnar C,Paola D L,et al.Long-term follow-up of Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia treated with the EsPhALL2004 study:high white blood cell count at diagnosis is the strongest prognostic factor[J].Haematologica,2019,104(1):e13-e16.
[15] Chen C C,Yang C F,Yang M H,et al.Pretreatment prognosis factors and treatment outcome in elderly patients with de novo acute myeloid leukemia[J].Annals of Oncology,2005,16(8):1366-1373.
[16] 刘华,郑沁,曾婷婷,等.动态监测血清乳酸脱氢酶水平在急性白血病中的临床意义研究[J].检验医学,2014,29 (6):622-627.
[17] Teng C L,Young J H,Hsu S L,et al.Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor,positively correlates to bone marrow vascularity in acute myeloid leukemia[J].Journal of the Chinese Medical Association,2006,69(11):534-537.
[18] Miller K C, Al-Kali A, Shah M V,et al.Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patients[J].Leuk Lymphoma,2018,2:1-10. |
